Function, Pain
Conditions
Keywords
femoral neck fractures, direct anterior approach, hemiarthroplasty
Brief summary
A prospective controlled study was conducted to include patients who received hip replacement surgery for femoral neck fractures at the National Regional Trauma Center in Fujian Province from February 2023 to August 2024. Patients were randomly divided into the DAA group and the PLA group based on different surgical methods for a 3-month follow-up to compare the outcomes of the two groups. The main observation results include Harris hip joint function score (preoperative, postoperative 1 week, 1 month, 3 months), VAS pain score (preoperative, postoperative 1 week, 1 month, 3 months), and secondary observation results include surgical time, intraoperative blood loss, blood transfusion rate, difference in HB before and after surgery, difference in CK before and after surgery, perioperative complications, difference in length of both lower limbs after surgery, postoperative drainage volume, postoperative ICU occupancy rate, ICU length of stay, and total length of stay.
Interventions
Direct anterior approach hemiarthroplasty
PROCEDUREPosterior lateral approach hemiarthroplasty
Posterior lateral approach hemiarthroplasty
Sponsors
Fujian Provincial Hospital Emergency Center
Fujian Provincial Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
80 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 80 years old; 2. Diagnosed with unilateral femoral neck fracture through imaging examination; 3. Patients who can tolerate surgery and agree to undergo surgery; 4. Undergoing hemiarthroplasty (HA) for the first time; 5. Able to walk independently and have intact cognitive function before the injury.
Exclusion criteria
1. Bilateral femoral neck fractures; 2. Patients with pathological fractures; 3. Hip dysplasia, rheumatoid osteoarthritis, or other hip disorders; 4. Patients with systemic or localized infections or inflammatory reactions at the surgical site; 5. Patients with other lower limb fractures or severe injuries to other parts of the body; Patients with a history of previous hip surgery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Harris hip joint function score | 1 week, 1 month, and 3 months after surgery | Scores range from 100 to 0, with 90-100 being excellent, 80-89 being good, 70-79 being acceptable, and ≤69 being poor. |
| VAS pain score | 1 week, 1 month, and 3 months after surgery | The highest score is 10 and the lowest score is 0, with the following interpretations: 0 points indicating no pain; 1-3 points indicating mild pain with little impact on daily life; 4-6 points indicating moderate pain affecting daily life and sleep; 7-9 points indicating severe pain significantly affecting quality of life; and 10 points indicating unbearable, extreme pain. |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative blood transfusion rate | Intraoperative |
| Hemoglobin value | Preoperative and postoperative 1 day |
| Blood creatine kinase value | Preoperative and postoperative 1 day |
| Incidence of complications | Perioperative period |
| Operative time | Intraoperative |
| Postoperative drainage volume | 24 hours after surgery |
| Hospital stay | The duration (in days) from admission to discharge, estimated to be no more than 21 days at most. |
| Mortality | 3 months after surgery |
| Difference in length of both lower limbs | 3 days after surgery |
| Intraoperative bleeding volume | Intraoperative |
Countries
China
Outcome results
None listed